| Ident. | Authors (with country if any) | Title |
|---|
| 000020 (2017) |
Andrew J. Lees [Royaume-Uni] ; Joaquim Ferreira [Portugal] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; José-Francisco Rocha [Portugal] ; Michelle Mccrory [Irlande (pays)] ; Patricio Soares-Da-Silva [Portugal] | Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial. |
| 000079 (2016-05-23) |
François Tison [France] ; Charlotte Keywood [Suisse] ; Mark Wakefield [France] ; Franck Durif [France] ; Jean-Christophe Corvol [France] ; Karla Eggert [France] ; Mark Lew [États-Unis] ; Stuart Isaacson [États-Unis] ; Erwan Bezard [France] ; Sonia-Maria Poli [Suisse] ; Christopher G. Goetz [États-Unis] ; Claudia Trenkwalder [Allemagne] ; Olivier Rascol [France] | A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease. |
| 000126 (2016) |
Jorik Nonnekes [Pays-Bas] ; Monique H M. Timmer [Pays-Bas] ; Nienke M. De Vries [Pays-Bas] ; Olivier Rascol [France] ; Rick C. Helmich [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] | Unmasking levodopa resistance in Parkinson's disease. |
| 000137 (2016) |
Santiago Perez-Lloret [Argentine] ; Olivier Rascol [France] | The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease. |
| 000194 (2016) |
Santiago Perez-Lloret [Argentine] ; Olivier Rascol [France] | Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease. |
| 000226 (2016) |
Gaetano Barbagallo [France] ; Maria Sierra-Pe A [Espagne] ; Federico Nemmi [Suède] ; Anne Pavy-Le Traon [France] ; Wassilios G. Meissner [France] ; Olivier Rascol [France] ; Patrice Péran [France] | Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease. |
| 000245 (2016) |
Olivier Rascol [France] ; Robert A. Hauser [États-Unis] ; Fabrizio Stocchi [Italie] ; Cheryl J. Fitzer-Attas [États-Unis] ; Yulia Sidi [Israël] ; Victor Abler [États-Unis] ; C Warren Olanow [États-Unis] | Long-term effects of rasagiline and the natural history of treated Parkinson's disease. |
| 000287 (2016) |
Joaquim J. Ferreira [Portugal] ; Tiago Mestre [Portugal] ; Leonor Correia Guedes [Portugal] ; Miguel Coelho [Portugal] ; Mário M. Rosa [Portugal] ; Ana T. Santos [Portugal] ; Márcio Barra [Portugal] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] | Espresso Coffee for the Treatment of Somnolence in Parkinson’s Disease: Results of n-of-1 Trials |
| 000347 (2016) |
Sibylle De Germay [France] ; Jean-Louis Montastruc [France] ; Vanessa Rousseau [France] ; Leila Chebane [France] ; Emmanuelle Bondon-Guitton [France] ; Florence Moulis [France] ; Genevieve Durrieu [France] ; Haleh Bagheri [France] ; Olivier Rascol [France] ; Antoine Pariente [France] ; Bernard Bégaud [France] ; François Montastruc [France] | Atropinic (Anticholinergic) Burden in Parkinson's Disease. |
| 000375 (2016) |
Olivier Rascol [France] ; Theresa Zesiewicz [États-Unis] ; K Ray Chaudhuri [Royaume-Uni] ; Mahnaz Asgharnejad [États-Unis] ; Erwin Surmann [Allemagne] ; Elisabeth Dohin [Belgique] ; Sigrid Nilius [Allemagne] ; Lars Bauer [Allemagne] | A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain. |
| 000376 (2016) |
Claudia Trenkwalder [Allemagne] ; Daniela Berg [Allemagne] ; Olivier Rascol [France] ; Karla Eggert [Allemagne] ; Andres Ceballos-Baumann [Allemagne] ; Jean-Christophe Corvol [France] ; Alexander Storch [Allemagne] ; Lin Zhang [États-Unis] ; Jean-Philippe Azulay [France] ; Emmanuel Broussolle [France] ; Luc Defebvre [France] ; Christian Geny [France] ; Michal Gostkowski [États-Unis] ; Fabrizio Stocchi [Italie] ; Christine Tranchant [France] ; Pascal Derkinderen [France] ; Franck Durif [France] ; Alberto J. Espay [États-Unis] ; Andrew Feigin [États-Unis] ; Jean-Luc Houeto [France] ; Johannes Schwarz [Allemagne] ; Thérèse Di Paolo [Canada] ; Dominik Feuerbach [Suisse] ; Hans-Ulrich Hockey [Suisse] ; Judith Jaeger [États-Unis] ; Annamaria Jakab [Suisse] ; Donald Johns [États-Unis] ; Gurutz Linazasoro [Espagne] ; Paul Maruff [États-Unis] ; Izabela Rozenberg [Suisse] ; Judit Sovago [Suisse] ; Markus Weiss [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia. |
| 000377 (2016) |
François Tison [France] ; Charlotte Keywood [Suisse] ; Mark Wakefield [Suisse] ; Franck Durif [France] ; Jean-Christophe Corvol [France] ; Karla Eggert [Allemagne] ; Mark Lew [États-Unis] ; Stuart Isaacson [États-Unis] ; Erwan Bezard [France] ; Sonia-Maria Poli [Suisse] ; Christopher G. Goetz [États-Unis] ; Claudia Trenkwalder [Allemagne] ; Olivier Rascol [France] | A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease. |
| 000502 (2015) |
Pietro-Luca Ratti [Suisse] ; Laurence Nègre-Pagès [France] ; Santiago Pérez-Lloret [France] ; Raffaele Manni [Italie] ; Philippe Damier [France] ; François Tison [France] ; Alain Destée [France] ; Olivier Rascol [France] | Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort. |
| 000527 (2015) |
Claudia Trenkwalder [Allemagne] ; K Ray Chaudhuri [Royaume-Uni] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Reinhard Ehret [Allemagne] ; Martin Vališ [République tchèque] ; Maria Sátori [Hongrie] ; Anna Krygowska-Wajs [Pologne] ; Maria J. Marti [Espagne] ; Karen Reimer [Allemagne] ; Alexander Oksche [Allemagne] ; Mark Lomax [Royaume-Uni] ; Julia Decesare [Royaume-Uni] ; Michael Hopp [Allemagne] | Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial. |
| 000535 (2015) |
Robert A. Hauser [États-Unis] ; Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Susan B. Huyck [États-Unis] ; Rachel Capece [États-Unis] ; Tony W. Ho [États-Unis] ; Peter Sklar [États-Unis] ; Christopher Lines [États-Unis] ; David Michelson [États-Unis] ; David Hewitt [États-Unis] | Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned. |
| 000537 (2015) |
Caroline Moreau [France] ; Sayah Meguig [France] ; Jean-Christophe Corvol [France] ; Julien Labreuche [France] ; Francis Vasseur [France] ; Alain Duhamel [France] ; Arnaud Delval [France] ; Thomas Bardyn [France] ; Jean-Christophe Devedjian [France] ; Nathalie Rouaix [France] ; Gregory Petyt [France] ; Christine Brefel-Courbon [France] ; Fabienne Ory-Magne [France] ; Dominique Guehl [France] ; Alexandre Eusebio [France] ; Valérie Fraix [France] ; Pierre-Jean Saulnier [France] ; Ouhaid Lagha-Boukbiza [France] ; Frank Durif [France] ; Mirela Faighel [France] ; Caroline Giordana [France] ; Sophie Drapier [France] ; David Maltête [France] ; Christine Tranchant [France] ; Jean-Luc Houeto [France] ; Bettina Debû [France] ; Jean-Philippe Azulay [France] ; François Tison [France] ; Alain Destée [France] ; Marie Vidailhet [France] ; Olivier Rascol [France] ; Kathy Dujardin [France] ; Luc Defebvre [France] ; Régis Bordet [France] ; Bernard Sablonnière [France] ; David Devos [France] | Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease. |
| 000547 (2015) |
Federico Nemmi [France] ; Umberto Sabatini [Italie] ; Olivier Rascol [France] ; Patrice Péran [France] | Parkinson's disease and local atrophy in subcortical nuclei: insight from shape analysis. |
| 000562 (2015) |
Olivier Rascol [France] ; Santiago Perez-Lloret ; Joaquim J. Ferreira [Portugal] | New treatments for levodopa-induced motor complications. |
| 000608 (2015) |
Clive Ballard [Royaume-Uni] ; Stuart Isaacson [États-Unis] ; Roger Mills [États-Unis] ; Hilde Williams [États-Unis] ; Anne Corbett [Royaume-Uni] ; Bruce Coate [États-Unis] ; Rajesh Pahwa [États-Unis] ; Olivier Rascol [France] ; David J. Burn [Royaume-Uni] | Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis. |
| 000636 (2015) |
Olivier Rascol [France] ; Santiago Perez-Lloret [France] ; Philippe Damier [France] ; Arnaud Delval [France] ; Pascal Derkinderen [France] ; Alain Destée [France] ; Wassilios G. Meissner [France] ; Francois Tison [France] ; Laurence Negre-Pages [France] | Falls in ambulatory non-demented patients with Parkinson's disease. |
| 000661 (2015) |
Pietro-Luca Ratti [France, Suisse] ; Maria Sierra-Pe A [France] ; Raffaele Manni [Italie] ; Marion Simonetta-Moreau [France] ; Julien Bastin [France] ; Harrison Mace [France] ; Olivier Rascol [France] ; Olivier David [France] | Distinctive Features of NREM Parasomnia Behaviors in Parkinson’s Disease and Multiple System Atrophy |
| 000771 (2014-07) |
Erwan Bezard [France] ; Elsa Y. Pioli [Royaume-Uni] ; Qin Li [Royaume-Uni] ; Françoise Girard [France] ; Vincent Mutel [Suisse] ; Charlotte Keywood [Suisse] ; Francois Tison [France] ; Olivier Rascol [France] ; Sonia M. Poli [Italie] | The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model |
| 000808 (2014) |
Fabienne Ory-Magne [France] ; Jean-Christophe Corvol ; Jean-Philippe Azulay ; Anne-Marie Bonnet ; Christine Brefel-Courbon ; Philippe Damier ; Estelle Dellapina ; Alain Destée [France] ; Franck Durif ; Monique Galitzky ; Thibaud Lebouvier ; Wassilios Meissner ; Claire Thalamas ; François Tison ; Alexandrine Salis ; Agnès Sommet ; François Viallet ; Marie Vidailhet ; Olivier Rascol | Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial. |
| 000815 (2014) |
Olivier Rascol [France] ; Susan Fox [Canada] ; Fabrizio Gasparini [Suisse] ; Christopher Kenney [États-Unis] ; Thérèse Di Paolo [Canada] ; Baltazar Gomez-Mancilla [Canada] | Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias. |
| 000855 (2014) |
Santiago Perez-Lloret [France] ; María Ver Nica Rey ; James Crispo ; Daniel Krewski ; Marise Lapeyre-Mestre ; Jean-Louis Montastruc ; Olivier Rascol | Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients. |
| 000872 (2014) |
Santiago Perez-Lloret ; Laurence Negre-Pages [France] ; Philippe Damier [France] ; Arnaud Delval [France] ; Pascal Derkinderen [France] ; Alain Destée [France] ; Wassilios G. Meissner [France] ; Ludwig Schelosky [Suisse] ; Francois Tison [France] ; Olivier Rascol | Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease. |
| 000895 (2014) |
Olivier Rascol [France] | Parkinson disease: Can a new trial end controversy over when to use levodopa? |
| 000910 (2014) |
Pierre-Olivier Fernagut [France] ; Benjamin Dehay [France] ; Aline Maillard [France] ; Erwan Bezard [France] ; Paul Perez [France] ; Anne Pavy-Le Traon [France] ; Olivier Rascol [France] ; Alexandra Foubert-Samier [France] ; François Tison [France] ; Wassilios G. Meissner [France] | Multiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies. |
| 000923 (2014) |
Robert A. Hauser [États-Unis] ; Mark Forrest Gordon [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Paolo Barone [Italie] ; Anthony H. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Catherine Debieuvre [France] ; Mandy Fr Dorf [Allemagne] | Minimal Clinically Important Difference in Parkinson's Disease as Assessed in Pivotal Trials of Pramipexole Extended Release |
| 000931 (2014) |
Stéphane Palfi [France] ; Jean Marc Gurruchaga [France] ; G Scott Ralph [Royaume-Uni] ; Helene Lepetit [France] ; Sonia Lavisse [France] ; Philip C. Buttery [Royaume-Uni] ; Colin Watts [Royaume-Uni] ; James Miskin [Royaume-Uni] ; Michelle Kelleher [Royaume-Uni] ; Sarah Deeley [Royaume-Uni] ; Hirokazu Iwamuro [France] ; Jean Pascal Lefaucheur [France] ; Claire Thiriez [France] ; Gilles Fenelon [France] ; Cherry Lucas [Royaume-Uni] ; Pierre Brugières [France] ; Inanna Gabriel [France] ; Kou Abhay [France] ; Xavier Drouot [France] ; Naoki Tani [France] ; Aurelie Kas [France] ; Bijan Ghaleh [France] ; Philippe Le Corvoisier [France] ; Patrice Dolphin [France] ; David P. Breen [Royaume-Uni] ; Sarah Mason [Royaume-Uni] ; Natalie Valle Guzman [Royaume-Uni] ; Nicholas D. Mazarakis [Royaume-Uni] ; Pippa A. Radcliffe [Royaume-Uni] ; Richard Harrop [Royaume-Uni] ; Susan M. Kingsman [Royaume-Uni] ; Olivier Rascol [France] ; Stuart Naylor [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Pierre Cesaro [France] ; Kyriacos A. Mitrophanous [Royaume-Uni] | Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. |
| 000939 (2014) |
Olivier Rascol [France] | Jejunal levodopa infusion in Parkinson's disease. |
| 000A75 (2014) |
María Ver Nica Rey [Argentine] ; Santiago Perez-Lloret ; Anne Pavy-Le Traon ; Wassilios G. Meissner ; Francois Tison ; Olivier Rascol | A cross-sectional study on drug use in multiple system atrophy. |
| 000A95 (2014) |
Fabienne Ory-Magne [France] ; Jean-Christophe Corvol [France] ; Jean-Philippe Azulay [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Philippe Damier [France] ; Estelle Dellapina [France] ; Alain Destée [France] ; Franck Durif [France] ; Monique Galitzky [France] ; Thibaud Lebouvier [France] ; Wassilios Meissner [France] ; Claire Thalamas [France] ; François Tison [France] ; Alexandrine Salis [France] ; Agnès Sommet [France] ; François Viallet [France] ; Marie Vidailhet [France] ; Olivier Rascol [France] | Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial |
| 000B02 (2014) |
Santiago Perez-Lloret [France] ; María Ver Nica Rey [France] ; James Crispo [Canada] ; Daniel Krewski [Canada] ; Marise Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] | Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients |
| 000B16 (2014) |
Stéphane Palfi [France] ; Jean Marc Gurruchaga [France] ; G. Scott Ralph [Royaume-Uni] ; Helene Lepetit [France] ; Sonia Lavisse [France] ; Philip C. Buttery [Royaume-Uni] ; Colin Watts [Royaume-Uni] ; James Miskin [Royaume-Uni] ; Michelle Kelleher [Royaume-Uni] ; Sarah Deeley [Royaume-Uni] ; Hirokazu Iwamuro [France] ; Jean Pascal Lefaucheur [France] ; Claire Thiriez [France] ; Gilles Fenelon [France] ; Cherry Lucas [Royaume-Uni] ; Pierre Brugieres [France] ; Inanna Gabriel [France] ; Kou Abhay [France] ; Xavier Drouot [France] ; Naoki Tani [France] ; Aurelie Kas [France] ; Bijan Ghaleh [France] ; Philippe Le Corvoisier [France] ; Patrice Dolphin [France] ; David P. Breen [Royaume-Uni] ; Sarah Mason [Royaume-Uni] ; Natalie Valle Guzman [Royaume-Uni] ; Nicholas D. Mazarakis [Royaume-Uni] ; Pippa A. Radcliffe [Royaume-Uni] ; Richard Harrop [Royaume-Uni] ; Susan M. Kingsman [Royaume-Uni] ; Olivier Rascol [France] ; Stuart Naylor [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Pierre Cesaro [France] ; Kyriacos A. Mitrophanous [Royaume-Uni] | Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial |
| 000C08 (2013) |
Gregor K. Wenning [Autriche] ; Felix Geser [Autriche, Allemagne] ; Florian Krismer [Autriche] ; Klaus Seppi [Autriche] ; Susanne Duerr [Autriche] ; Sylvia Boesch [Autriche] ; Martin Köllensperger [Autriche] ; Georg Goebel ; Karl P. Pfeiffer [Autriche] ; Paolo Barone [Italie] ; Maria Teresa Pellecchia [Italie] ; Niall P. Quinn [Royaume-Uni] ; Vasiliki Koukouni [Royaume-Uni] ; Clare J. Fowler [Royaume-Uni] ; Anette Schrag [Royaume-Uni] ; Christopher J. Mathias [Royaume-Uni] ; Nir Giladi [Israël] ; Tanya Gurevich [Israël] ; Erik Dupont [Danemark] ; Karen Ostergaard [Danemark] ; Christer F. Nilsson [Suède] ; H Kan Widner [Suède] ; Wolfgang Oertel [Allemagne] ; Karla Maria Eggert [Allemagne] ; Alberto Albanese [Italie] ; Francesca Del Sorbo [Italie] ; Eduardo Tolosa [Espagne] ; Adriana Cardozo [Espagne] ; Günther Deuschl [Allemagne] ; Helge Hellriegel [Allemagne] ; Thomas Klockgether [Allemagne] ; Richard Dodel [Allemagne] ; Cristina Sampaio [Portugal] ; Miguel Coelho [Portugal] ; Ruth Djaldetti [Israël] ; Eldad Melamed [Israël] ; Thomas Gasser [Allemagne] ; Christoph Kamm [Allemagne] ; Giuseppe Meco [Italie] ; Carlo Colosimo [Italie] ; Olivier Rascol [France] ; Wassilios G. Meissner [France] ; François Tison [France] ; Werner Poewe [Autriche] | The natural history of multiple system atrophy: a prospective European cohort study |
| 000C35 (2013) |
François Tison [France] ; Laurence Nègre-Pagès ; Wassilios G. Meissner ; Sandrine Dupouy ; Qin Li ; Marie-Laure Thiolat ; Thibaud Thiollier ; Monique Galitzky ; Fabienne Ory-Magne ; Agathe Milhet ; Laurent Marquine ; Umberto Spampinato ; Olivier Rascol ; Erwan Bezard | Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over ("n-of-1") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients. |
| 000C40 (2013) |
Jens Volkmann [Allemagne] ; Alberto Albanese [Italie] ; Angelo Antonini [Italie] ; K. Ray Chaudhuri [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Rob M. A. De Bie [Pays-Bas] ; Günther Deuschl [Allemagne] ; Karla Eggert [Allemagne] ; Jean-Luc Houeto [France] ; Jaime Kulisevsky [Espagne] ; Dag Nyholm [Suède] ; Per Odin [Allemagne] ; Karen Stergaard [Danemark] ; Werner Poewe [Autriche] ; Pierre Pollak [Suisse] ; Jose Martin Rabey [Israël] ; Olivier Rascol [France] ; Evzen Ruzicka [République tchèque] ; Michael Samuel [Royaume-Uni] ; Hans Speelman [Pays-Bas] ; Olof Sydow [Suède] ; Francesc Valldeoriola [Espagne] ; Chris Van Der Linden [Belgique] ; Wolfgang Oertel [Allemagne] | Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review |
| 000C54 (2013) |
Anthony Hv Schapira [Royaume-Uni] ; Michael P. Mcdermott [États-Unis] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Stefan Albrecht [Allemagne] ; Helen H. Hsu [États-Unis] ; Daniel H. Massey [Royaume-Uni] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis] | Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial |
| 000C72 (2013) |
Christine Brefel-Courbon [France] ; Fabienne Ory-Magne ; Claire Thalamas ; Pierre Payoux ; Olivier Rascol | Nociceptive brain activation in patients with neuropathic pain related to Parkinson's disease. |
| 000D25 (2013) |
Olivier Rascol [France] | Extended-release carbidopa-levodopa in Parkinson's disease. |
| 000D29 (2013) |
Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Anne Pavy-Le Traon ; Olivier Rascol | Emerging drugs for autonomic dysfunction in Parkinson's disease. |
| 000E05 (2013) |
Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Kathryn A. Chung [États-Unis] ; Robert A. Hauser [États-Unis] ; Janis M. Miyasaki [Canada] ; Anthony P. Nicholas [États-Unis] ; Werner Poewe [Autriche] ; Klaus Seppi [Autriche] ; Olivier Rascol [France] ; Mark A. Stacy [États-Unis] ; John G. Nutt [États-Unis] ; Caroline M. Tanner [États-Unis] ; Alison Urkowitz [États-Unis] ; Jean A. Jaglin [États-Unis] ; Song Ge [États-Unis] | Which dyskinesia scale best detects treatment response? |
| 000E10 (2013) |
Anthony E. Lang [Canada] ; Eldad Melamed [Israël] ; Werner Poewe [Autriche] ; Olivier Rascol [France] | Trial designs used to study neuroprotective therapy in Parkinson's disease |
| 000E34 (2013) |
Santiago Perez-Lloret [Argentine] ; María Ver Nica Rey ; Pietro Lucca Ratti ; Olivier Rascol | Rotigotine transdermal patch for the treatment of Parkinson’s Disease |
| 000E42 (2013) |
Olivier Rascol [France] | Physical exercise in Parkinson disease: Moving toward more robust evidence? |
| 000E80 (2013) |
C. Warren Olanow [États-Unis, Italie] ; Karl Kieburtz [États-Unis] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Anthony H. Schapira [Royaume-Uni] ; Murat Emre [Turquie] ; Helena Nissinen [Finlande] ; Mika Leinonen [Suède] ; Fabrizio Stocchi [Italie] | Factors predictive of the development of Levodopa‐induced dyskinesia and wearing‐off in Parkinson's disease |
| 000F16 (2013) |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Alain Destée [France] ; Nobutaka Hattori [Japon] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Werner Poewe [Autriche] ; Mark Stacy [États-Unis] ; Eduardo Tolosa [Espagne] ; Haitao Gao [États-Unis] ; Jennifer Nagel [Suisse] ; Martin Merschhemke [Suisse] ; Ana Graf [Suisse] ; Christopher Kenney [États-Unis] ; Claudia Trenkwalder [Allemagne] | AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding study |
| 000F53 (2013) |
Santiago Perez-Lloret [France, Argentine] ; Maria Veronica Rey [France] ; Pietro Lucca Ratti [France] ; Olivier Rascol [France] | Rotigotine transdermal patch for the treatment of Parkinson's Disease |
| 001102 (2012) |
Caroline Moreau [France] ; Arnaud Delval ; Luc Defebvre [France] ; Kathy Dujardin ; Alain Duhamel ; Gregory Petyt ; Isabelle Vuillaume ; Jean-Christophe Corvol ; Christine Brefel-Courbon ; Fabienne Ory-Magne ; Dominique Guehl ; Alexandre Eusebio ; Valérie Fraix ; Pierre-Jean Saulnier ; Ouhaid Lagha-Boukbiza ; Frank Durif ; Mirela Faighel ; Caroline Giordana ; Sophie Drapier ; David Maltête ; Christine Tranchant ; Jean-Luc Houeto ; Bettina Debû ; Bernard Sablonniere ; Jean-Philippe Azulay ; François Tison ; Olivier Rascol ; Marie Vidailhet ; Alain Destée [France] ; Bastiaan R. Bloem ; Régis Bordet ; David Devos | Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. |
| 001136 (2012) |
Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Nelly Fabre ; Fabienne Ory ; Umberto Spampinato ; Jean-Michel Senard ; Anne Pavy-Le Traon ; Jean-Louis Montastruc ; Olivier Rascol | Factors related to orthostatic hypotension in Parkinson's disease. |
